FEMTOBIOMED Inc. is a biotechnology company specializing in non-viral gene delivery and next-generation electroporation systems for cell and gene therapy manufacturing. Its proprietary CellShot® PFEP™ technology enables high-efficiency transfection without cytotoxic buffers or washing steps, ensuring superior scalability and safety. With FDA Drug Master File registration, FEMTOBIOMED partners globally to provide advanced, cGMP-compliant solutions development of innovative cellular therapeutics.
Products